Status:

COMPLETED

Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux Disease

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Gastroesophageal Reflux Disease

Eligibility:

All Genders

20-70 years

Brief Summary

Gastroesophageal reflux disease (GERD) is a common disorder in Asia that includes erosive and non-erosive counterparts. The evaluation of intra-esophageal damage is of paramount importance because pat...

Detailed Description

Gastroesophageal reflux disease (GERD) is a common disorder in Asia that includes erosive and non-erosive counterparts. The evaluation of intra-esophageal damage is of paramount importance because pat...

Eligibility Criteria

Inclusion

  • Symptomatic reflux subjects who receive esophagogastroscopy, aged from 20 to 70 years old.
  • Patients with typical reflux symptoms (heartburn and/or acid regurgitation) at least 3 times per week in recent 4 months.

Exclusion

  • Symptomatic reflux patients with apparent erosive esophagitis in conventional endoscopy.
  • Symptomatic reflux patients with a history of using PPI in recent 4 months.
  • Subjects with known allergy to PPI.
  • Peptic ulcer disease
  • Cancers of the esophagus, stomach, and duodenum
  • Esophageal varices.
  • Active upper gastrointestinal bleeding within 7 days prior to enrollment
  • Status after total or subtotal gastrectomy
  • Use of anticoagulants or antiplatelets within one week prior to enrollment
  • Subjects with bleeding tendency

Key Trial Info

Start Date :

September 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2009

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00886197

Start Date

September 1 2007

End Date

April 1 2009

Last Update

April 22 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taiwan, 100